Moreover, the effect of RPL35A on ovarian cancer cell invasion was further confirmed through Transwell experiments, which showed a significant inhibition of invasion ability in shRPL35A HO‐8910 and SK‐OV‐3 cells compared to shCtrl cells (p < 0.05; Figure 3C). This evidence concerns the gene RPL35A and ovarian carcinoma.